Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novo Nordisk A/S
  6. News
  7. Summary
    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe Europe - 01/25 11:00:00 am
625.2 DKK   +2.68%
11:06aLiberum Capital Downgrades Novo Nordisk to Sell from Hold
MT
03:37aNOVO NORDISK : Gets a Neutral rating from JP Morgan
MD
01/24Novo Nordisk A/S – Share repurchase programme
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Novo Nordisk Secures Canadian Approval for Weight Loss Drug Wegovy

11/26/2021 | 07:51am EST


ę MT Newswires 2021
All news about NOVO NORDISK A/S
11:06aLiberum Capital Downgrades Novo Nordisk to Sell from Hold
MT
03:37aNOVO NORDISK : Gets a Neutral rating from JP Morgan
MD
01/24Novo Nordisk A/S – Share repurchase programme
AQ
01/24NOVO NORDISK : Gets a Buy rating from Bernstein
MD
01/21Novo Nordisk Repurchases 4 Million B Shares Under Stock Buyback Plan
MT
01/20Arecor Therapeutics Initiates Early-Stage Clinical Trial for Insulin Formation
MT
01/14Novo Nordisk Settles Securities Case in Denmark
MT
01/14Novo Nordisk announces settlement of securities lawsuit in Denmark
AQ
01/10Novo Nordisk A/S – Share repurchase programme
AQ
01/062Seventy Bio Working With Novo Nordisk to Develop Potential Gene-Editing Treatment for ..
MT
More news
Analyst Recommendations on NOVO NORDISK A/S
More recommendations
Financials
Sales 2021 140 B 21 226 M 21 226 M
Net income 2021 47 541 M 7 217 M 7 217 M
Net Debt 2021 1 345 M 204 M 204 M
P/E ratio 2021 29,4x
Yield 2021 1,67%
Capitalization 1 387 B 210 B 211 B
EV / Sales 2021 9,93x
EV / Sales 2022 9,02x
Nbr of Employees 46 982
Free-Float -
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO B | DK0060534915 | MarketScreener
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 27
Last Close Price 608,90 DKK
Average target price 669,29 DKK
Spread / Average Target 9,92%
EPS Revisions
Managers and Directors
Lars Fruergaard J°rgensen President & Chief Executive Officer
Karsten Munk Knudsen Chief Financial Officer & Executive Vice President
Helge Lund Chairman
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Henrik Ehlers Wulff Senior Vice President-Diabetes API
Sector and Competitors
1st jan.Capi. (M$)
NOVO NORDISK A/S-17.16%210 749
JOHNSON & JOHNSON-4.73%429 034
ROCHE HOLDING AG-9.06%304 714
PFIZER, INC.-12.72%289 287
ABBVIE INC.-2.39%233 643
ELI LILLY AND COMPANY-12.00%217 963